论文部分内容阅读
胃病是常见病,其用药规模在消化系统中居于第1位,预计我国临床年销售额约为43亿元人民币。目前整个胃病用药的销售平稳增长,2006年年销售金额增长率为16.5%,高于目前医药整体销售增长率,2002 -2006年5年的复合增长率(CAGR)为16.3%。从整体形势上看,销售额的增长速度高于销售数量(见图1),而单位平均价格指数直线上升(见图2),说明本类药物中高价位药物正在逐步替代低价位药物,这是导致销售增长的主要原因。
Stomach disease is a common disease, the scale of its use of drugs in the digestive system in the first place, is expected to clinically China’s annual sales of about 4.3 billion yuan. At present, sales of the entire stomach medicine have been steadily increasing. The annual sales growth in 2006 was 16.5%, higher than the current overall pharmaceutical sales growth. The CAGR of the five years 2002-2006 was 16.3%. From the overall situation, the sales growth rate higher than the sales volume (see Figure 1), while the average unit price index rose (see Figure 2), indicating that high-priced drugs in this class are gradually replacing low-cost drugs, which Is the main reason for sales growth.